Alzamend Neuro (ALZN) Cash & Equivalents (2020 - 2026)
Alzamend Neuro (ALZN) recorded Cash & Equivalents of $7.59 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 35.1% from $5.62 million a year earlier and up 968.2% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Alzamend Neuro reported Cash & Equivalents of $710,689, down 82.0% from FY2025.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -18.1% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Equivalents came in at $3.95 million in FY2025 (+950.0%), $376,048 in FY2024 (-92.7%), $5.14 million in FY2023 (-63.4%) and $14.06 million in FY2022 (+629.0%).
- The fiscal Q1 2027 figure is the highest quarterly Cash & Equivalents since fiscal Q2 2023.
- On a year-over-year basis, Cash & Equivalents rose in four of the last six quarters, with growth averaging 210.6%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 950.0% in fiscal Q4 2025, against a decline of 97.8% in fiscal Q2 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $710,689 (Q4 2026), $2.71 million (Q3 2026) and $4.45 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Alzamend Neuro | 6.61 Mn | 6.61 Mn | - | 7.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 7.59 Mn |
| Apr 30, 2026 | 710,689.00 |
| Jan 31, 2026 | 2.71 Mn |
| Oct 31, 2025 | 4.45 Mn |
| Jul 31, 2025 | 5.62 Mn |
| Apr 30, 2025 | 3.95 Mn |
| Jan 31, 2025 | 3.36 Mn |
| Oct 31, 2024 | 4.09 Mn |
| Jul 31, 2024 | 1.19 Mn |
| Apr 30, 2024 | 376,048.00 |
| Jan 31, 2024 | 282,867.00 |
| Oct 31, 2023 | 200,079.00 |
| Jul 31, 2023 | 1.70 Mn |
| Apr 30, 2023 | 5.14 Mn |
| Jan 31, 2023 | 7.38 Mn |
| Oct 31, 2022 | 9.18 Mn |
| Jul 31, 2022 | 11.53 Mn |
| Apr 30, 2022 | 14.06 Mn |
| Jan 31, 2022 | 11.79 Mn |
| Oct 31, 2021 | 13.57 Mn |
API Access
Alzamend Neuro Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();